The usefulness of technetium-99m tetrofosmin scan to detect non-Hodgkin's lymphoma.
The aim of this study was to evaluate the usefulness of the Tc-99m tetrofosmin (Tc-99m TF) scan to detect Non-Hodgkin's lymphoma (NHL). Before any therapy, 26 patients with NHL were included in this study to undergo Tc-99m TF scan. Whole body Tc-99m TF scan was performed 10 minutes after intravenous injection of 20 mCi Tc-99m TF. Tc-99m TF scan could detect NHL in 22 (84.6%) patients. However, there were no significant differences in the incidences of positive and negative Tc-99m TF scan results between female versus male patients, age > 40 years and < or = 40 years patients, stage I-II versus stage III-IV patients and patients with versus without B symptoms (p values > 0.05). Four (15.4%) infradiaphragmatic NHL had false-negative Tc-99m TF scan results. We concluded that the Tc-99m TF scan is a potential tool to detect supradiaphragmatic NHL.
Liu
Feng-Yuan
FY
Department of Nuclear Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan.
Shiau
Yu-Chien
YC
Kao
Albert
A
Liang
Ji-An
JA
Yang
Shih-Neng
SN
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging*; D008297:Male; D008875:Middle Aged; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals
D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C078700:technetium tc-99m tetrofosmin